SEC Form 4 · accession 0001437749-17-008791
Oxford Immunotec Global PLC · OXFD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard A Sandberg
Director
Period of report
May 10, 2017
Accepted (ET)
May 11, 2017 · 5:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001586049
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | May 10, 2017 | M | 3,000 | $0.81 | A | 20,174 | D | |
| Ordinary Shares | May 10, 2017 | S | 3,000 | $14.40 | D | 17,174 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.81 | May 10, 2017 | M | 3,000 | D | — | Dec 31, 2022 | Ordinary Shares | 3,000 | 5,778 | D |
Explanation of responses
- F1Exercise from an option granted November 7, 2012, which became fully vested on December 31, 2016.